跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
康新博 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Isavuconazonium Sulfate Capsules
Approved
化学药品
Isavuconazonium Sulfate Capsules
PFIZER AUSTRALIA PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Dec 14, 2021
Approval ID
8DqliMFBltH
Company
PFIZER AUSTRALIA PTY LTD
Type
化学药品
Approval Details
Approval Id
8DqliMFBltH
Approval Number
国药准字HJ20210079
Generic Name
硫酸艾沙康唑胶囊
Generic Name En
Isavuconazonium Sulfate Capsules
Trade Name
康新博
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
100mg(按C₂₂H₁₇F₂N₅OS计)
Reg Date
2021-12-14
Expired Date
2026-12-13
Company Name
PFIZER AUSTRALIA PTY LTD
Production Company Name
SwissCo Services AG
Company Detail Path
/organization/pfizer-australia-pty-ltd
Production Company Detail Path
/organization/swissco-services-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 14, 2021
Approval ID
8DqliMFBltH
Type
化学药品
Back to NMPA Approvals